PFM Health Sciences, LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
PFM Health Sciences, LP disclosed 74 US equity positions worth $1.7bn in its Q3 2024 13F filing. The largest position was LLY at 15.2% of the reported book, followed by THC and CYTK.
What did PFM Health Sciences, LP own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | LLY ELI LILLY & CO | Healthcare | 15.2% | $264.6m | 298,643 | – | |
| 2 | THC TENET HEALTHCARE CORP | Healthcare | 5.6% | $98.0m | 589,409 | – | |
| 3 | CYTK CYTOKINETICS INC | Healthcare | 5.3% | $92.8m | 1,757,192 | – | |
| 4 | ABBV ABBVIE INC | Healthcare | 4.6% | $79.8m | 403,861 | – | |
| 5 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 4.0% | $69.2m | 148,852 | – | |
| 6 | ISRG INTUITIVE SURGICAL INC | Healthcare | 3.9% | $67.5m | 137,327 | – | |
| 7 | MRK MERCK & CO INC | Healthcare | 3.5% | $61.6m | 542,811 | – | |
| 8 | HCA HCA HEALTHCARE INC | Healthcare | 2.9% | $50.7m | 124,840 | – | |
| 9 | UHS UNIVERSAL HLTH SVCS INC | Healthcare | 2.8% | $49.0m | 213,983 | – | |
| 10 | MCK MCKESSON CORP | Healthcare | 2.8% | $48.2m | 97,498 | – | |
| 11 | ARGX ARGENX SE | Healthcare | 2.7% | $47.1m | 86,832 | – | |
| 12 | UNH UNITEDHEALTH GROUP INC | Healthcare | 2.5% | $44.2m | 75,588 | – | |
| 13 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 2.5% | $43.5m | 686,150 | – | |
| 14 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 2.4% | $42.0m | 467,427 | – | |
| 15 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 2.1% | $36.1m | 58,433 | – | |
| 16 | DHR DANAHER CORPORATION | Healthcare | 2.0% | $34.9m | 125,515 | – | |
| 17 | ICLR ICON PLC | Healthcare | 1.9% | $33.5m | 116,532 | – | |
| 18 | PEN PENUMBRA INC | Healthcare | 1.9% | $32.3m | 166,261 | – | |
| 19 | HUM HUMANA INC | Healthcare | 1.9% | $32.3m | 101,954 | – | |
| 20 | ELV ELEVANCE HEALTH INC | Healthcare | 1.7% | $29.3m | 56,441 | – | |
| 21 | AMGN AMGEN INC | Healthcare | 1.7% | $29.1m | 90,297 | – | |
| 22 | ASND ASCENDIS PHARMA A/S | 1.5% | $26.8m | 23,000,000 | – | ||
| 23 | IQV IQVIA HLDGS INC | Healthcare | 1.5% | $26.5m | 111,854 | – | |
| 24 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 1.5% | $25.8m | 390,863 | – | |
| 25 | BDX BECTON DICKINSON & CO | Healthcare | 1.4% | $24.5m | 101,680 | – | |
| 26 | SYK STRYKER CORPORATION | Healthcare | 1.4% | $24.2m | 67,014 | – | |
| 27 | MOH MOLINA HEALTHCARE INC | Healthcare | 1.4% | $24.1m | 70,088 | – | |
| 28 | INSP INSPIRE MED SYS INC | Healthcare | 1.2% | $20.8m | 98,322 | – | |
| 29 | WAT WATERS CORP | Healthcare | 1.1% | $18.4m | 51,063 | – | |
| 30 | OSCR OSCAR HEALTH INC | Healthcare | 1.0% | $18.3m | 860,821 | – | |
| 31 | EPIEUR ESSA PHARMA INC | 1.0% | $16.6m | 2,742,936 | – | ||
| 32 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.8% | $13.6m | 90,766 | – | |
| 33 | ERAS ERASCA INC | Healthcare | 0.8% | $13.3m | 4,876,911 | – | |
| 34 | XBI SPDR SER TR | 0.7% | $12.0m | 121,845 | – | ||
| 35 | INSM INSMED INC | Healthcare | 0.6% | $11.1m | 152,228 | – | |
| 36 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.6% | $11.0m | 88,216 | – | |
| 37 | CELC CELCUITY INC | Healthcare | 0.6% | $10.6m | 710,255 | – | |
| 38 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.6% | $10.5m | 183,092 | – | |
| 39 | ADAPY ADAPTIMMUNE THERAPEUTICS PLC | Healthcare | 0.5% | $9.5m | 10,000,787 | – | |
| 40 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 0.5% | $9.1m | 108,469 | – | |
| 41 | SRPT SAREPTA THERAPEUTICS INC | 0.5% | $8.8m | 7,750,000 | – | ||
| 42 | CRBU CARIBOU BIOSCIENCES INC | Healthcare | 0.5% | $8.4m | 4,306,671 | – | |
| 43 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 0.5% | $8.2m | 423,910 | – | |
| 44 | HOWL WEREWOLF THERAPEUTICS INC | 0.4% | $7.2m | 3,398,747 | – | ||
| 45 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.4% | $7.1m | 179,878 | – | |
| 46 | CON CONCENTRA GROUP HOLDINGS PAR | 0.4% | $6.7m | 300,000 | – | ||
| 47 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.3% | $5.9m | 101,050 | – | |
| 48 | ALKS ALKERMES PLC | Healthcare | 0.3% | $5.7m | 205,073 | – | |
| 49 | ITCIEUR INTRA-CELLULAR THERAPIES INC | 0.3% | $5.7m | 77,387 | – | ||
| 50 | TGTX TG THERAPEUTICS INC | Healthcare | 0.3% | $5.5m | 233,410 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.